Education
About Us
Working with TipRanks
Follow Us
Ka Yin Keith Li Insider Profile
4 Followers
Ka Yin Keith Li, Chief Financial Officer at Pharmadrug, holds 50.00K shares in US Critical Metals Corp. (Ticker: TSE:USCM), holds 250.00K shares in Psyched Wellness (Ticker: PSYCF), holds 400.00K shares in Silver Eagle Mines Inc. (Ticker: TSE:NOP). Most recently, Ka Yin Keith Li Bought ― shares of US Critical Metals Corp. on Apr 30, 2025 for an estimated value of 5.00K.
Ka Yin Keith Li Pharmadrug (PHRX)Chief Financial Officer
Pharmadrug (PHRX)
Chief Financial Officer
Ranked #13,309 out of 102,596 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+73.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Ka Yin Keith Li holds in companies
Most Profitable Insider Trade
The most profitable trade made by Ka Yin Keith Li
Ka Yin Keith Li's Trading History
Pharmadrug
Sep 01, 2020
Chief Financial Officer
Informative Buy
―
C$1.50K
Psyched Wellness
May 04, 2024
Chief Financial Officer
Uninformative Sell
―
$4.50K
Silver Eagle Mines Inc.
Mar 14, 2024
Chief Financial Officer
Uninformative Buy
12.50K
C$18.00K
US Critical Metals Corp.
Apr 30, 2025
Senior Officer
Informative Buy
5.00K
C$17.00K
List of latest transactions for each holding click on a transaction to see Ka Yin Keith Li's performance on stock
You May Also Like
Ka Yin Keith Li insider profile FAQ
What is the percentage of profitable transactions made by Ka Yin Keith Li?
The percentage of profitable transactions made by Ka Yin Keith Li is 67%.
What is the average return per transaction made by Ka Yin Keith Li?
The average return per transaction made by Ka Yin Keith Li is 73.30%.
What stocks does Ka Yin Keith Li hold?
Ka Yin Keith Li holds: TSE:PHRX, PSYCF, TSE:NOP, TSE:USCM stocks.
What was Ka Yin Keith Li’s latest transaction?
Ka Yin Keith Li latest transaction was an Informative Buy of C$5.00K.
What was Ka Yin Keith Li's most profitable transaction?
Ka Yin Keith Li’s most profitable transaction was an Informative Buy of TSE:USCM stock on April 30, 2025. The return on the trade was 158.80%.
What is Ka Yin Keith Li's role in Pharmadrug?
Ka Yin Keith Li's role in Pharmadrug is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.